Skip to content
Disclosery

Boxer Capital, LLC

Follow

13F filer, CIK 1465837, San Diego, CA

Boxer Capital, LLC reported $2,024,741,156 across 59 holdings for the quarter ended 2024-03-31, in a 13F-HR filed 2024-05-15. Its ten largest share positions make up 53.81% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000895345-24-000182

Period
2024-03-31
Reported value
$2.02B
Holdings
59
Top 10 weight
53.81%
New
13
Sold out
6

Largest buys vs the previous quarter

SecurityShares changeApprox. value
FATEadded+7,715,910$56.6M
NKTXadded+4,167,350$45M
VKTXnew+300,000$24.6M
KURAnew+1,000,000$21.3M
ALLOnew+3,850,000$17.2M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
MIRATI THERAPEUTICS INCexited-3,201,440-$188M
IMMUNOGEN INCexited-2,961,000-$87.8M
KARUNA THERAPEUTICS INCexited-250,000-$79.1M
ARGXreduced-60,000-$23.6M
IOVAreduced-650,000-$9.63M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2024

Share positions as resolved from 13F-HR 0000895345-24-000182, largest first. % of portfolio is the value over $2,024,741,156, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
SPRINGWORKS THERAPEUTICS INCSPRINGWORKS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 3,421,541 shares; 2023Q2: 3,421,541 shares; 2023Q3: 3,421,541 shares; 2023Q4: 3,421,541 shares; 2024Q1: 3,421,541 shares 3,421,541$168M8.32%0
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 2,100,000 shares; 2023Q2: 2,100,000 shares; 2023Q3: 2,100,000 shares; 2023Q4: 2,100,000 shares; 2024Q1: 2,100,000 shares 2,100,000$147M7.27%0Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 4,684,264 shares; 2023Q2: 4,684,264 shares; 2023Q3: 4,684,264 shares; 2023Q4: 4,279,464 shares; 2024Q1: 4,279,464 shares 4,279,464$138M6.81%0Timeline
TYRATYRA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 6,448,359 shares; 2023Q2: 6,448,359 shares; 2023Q3: 6,448,359 shares; 2023Q4: 6,448,359 shares; 2024Q1: 6,448,359 shares 6,448,359$106M5.22%0Timeline
APLSAPELLIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,576,000 shares; 2023Q2: 1,576,000 shares; 2023Q3: 1,726,000 shares; 2023Q4: 1,726,000 shares; 2024Q1: 1,726,000 shares 1,726,000$101M5.01%0Timeline
IDYAIDEAYA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 2,202,812 shares; 2023Q2: 2,202,812 shares; 2023Q3: 2,202,812 shares; 2023Q4: 2,202,812 shares; 2024Q1: 2,202,812 shares 2,202,812$96.7M4.77%0Timeline
MERUS N VMERUS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,900,000 shares; 2023Q2: 1,900,000 shares; 2023Q3: 1,900,000 shares; 2023Q4: 1,900,000 shares; 2024Q1: 1,900,000 shares 1,900,000$85.6M4.23%0
SRPTSAREPTA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 775,000 shares; 2023Q2: 600,000 shares; 2023Q3: 600,000 shares; 2023Q4: 650,000 shares; 2024Q1: 650,000 shares 650,000$84.1M4.16%0Timeline
NUVLNUVALENT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,210,192 shares; 2023Q2: 1,210,192 shares; 2023Q3: 1,210,192 shares; 2023Q4: 1,120,192 shares; 2024Q1: 1,120,192 shares 1,120,192$84.1M4.15%0Timeline
ONCBEONE MEDICINES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 500,000 shares; 2023Q2: 500,000 shares; 2023Q3: 500,000 shares; 2023Q4: 500,000 shares; 2024Q1: 500,000 shares 500,000$78.2M3.86%0Timeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 7,123,642 shares; 2023Q2: 7,123,642 shares; 2023Q3: 7,123,642 shares; 2023Q4: 8,198,642 shares; 2024Q1: 8,198,642 shares 8,198,642$65.1M3.22%0Timeline
NKTXNKARTA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: 1,440,000 shares; 2024Q1: 5,607,350 shares 5,607,350$60.6M2.99%+4,167,350Timeline
FATEFATE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 500,000 shares; 2023Q2: 500,000 shares; 2023Q3: 500,000 shares; 2023Q4: 500,000 shares; 2024Q1: 8,215,910 shares 8,215,910$60.3M2.98%+7,715,910Timeline
RNAMAVIDITY BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,121,327 shares; 2023Q2: 1,121,327 shares; 2023Q3: 1,121,327 shares; 2023Q4: 1,121,327 shares; 2024Q1: 1,727,388 shares 1,727,388$44.1M2.18%+606,061Timeline
AKROAKERO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 831,495 shares; 2023Q2: 1,676,733 shares; 2023Q3: 1,676,733 shares; 2023Q4: 1,676,733 shares; 2024Q1: 1,676,733 shares 1,676,733$42.4M2.09%0Timeline
RCKTROCKET PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,466,051 shares; 2023Q2: 1,466,051 shares; 2023Q3: 1,466,051 shares; 2023Q4: 1,466,051 shares; 2024Q1: 1,466,051 shares 1,466,051$39.5M1.95%0Timeline
ARGXARGENX SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: 75,000 shares; 2023Q3: 85,000 shares; 2023Q4: 160,000 shares; 2024Q1: 100,000 shares 100,000$39.4M1.94%-60,000Timeline
LEGNLEGEND BIOTECH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: 600,000 shares; 2023Q3: 600,000 shares; 2023Q4: 600,000 shares; 2024Q1: 600,000 shares 600,000$33.7M1.66%0Timeline
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 400,000 shares; 2023Q2: 400,000 shares; 2023Q3: 400,000 shares; 2023Q4: 400,000 shares; 2024Q1: 400,000 shares 400,000$31.9M1.58%0Timeline
RCUSARCUS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,432,200 shares; 2023Q2: 1,602,200 shares; 2023Q3: 1,602,200 shares; 2023Q4: 1,602,200 shares; 2024Q1: 1,602,200 shares 1,602,200$30.2M1.49%0Timeline
ANABANAPTYSBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,300,000 shares; 2023Q2: 1,300,000 shares; 2023Q3: 1,300,000 shares; 2023Q4: 1,300,000 shares; 2024Q1: 1,300,000 shares 1,300,000$29.3M1.45%0Timeline
IMVTIMMUNOVANT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: 750,000 shares; 2023Q4: 1,000,000 shares; 2024Q1: 825,000 shares 825,000$26.7M1.32%-175,000Timeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 600,000 shares; 2023Q2: 600,000 shares; 2023Q3: 600,000 shares; 2023Q4: 600,000 shares; 2024Q1: 600,000 shares 600,000$25.8M1.28%0Timeline
ARVNARVINAS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: 608,614 shares; 2024Q1: 608,614 shares 608,614$25.1M1.24%0Timeline
ITEOS THERAPEUTICS INCITEOS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 2,154,058 shares; 2023Q2: 2,154,058 shares; 2023Q3: 1,804,058 shares; 2023Q4: 1,804,058 shares; 2024Q1: 1,804,058 shares 1,804,058$24.6M1.22%0
VKTXVIKING THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 2,000,000 shares; 2023Q2: 2,000,000 shares; 2023Q3: 2,000,000 shares; 2023Q4: not reported; 2024Q1: 300,000 shares 300,000$24.6M1.21%newTimeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,054,000 shares; 2023Q2: 1,732,571 shares; 2023Q3: 1,732,571 shares; 2023Q4: 1,732,571 shares; 2024Q1: 1,732,571 shares 1,732,571$23.8M1.18%0Timeline
KURAKURA ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: 1,000,000 shares 1,000,000$21.3M1.05%newTimeline
GERNGERON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: 3,000,000 shares; 2023Q3: 3,000,000 shares; 2023Q4: 3,000,000 shares; 2024Q1: 6,000,000 shares 6,000,000$19.8M0.98%+3,000,000Timeline
DAWNDAY ONE BIOPHARMACEUTICALS IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,189,943 shares; 2023Q2: 1,189,943 shares; 2023Q3: 1,189,943 shares; 2023Q4: 1,189,943 shares; 2024Q1: 1,189,943 shares 1,189,943$19.7M0.97%0Timeline
THRDTHIRD HARMONIC BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 570,417 shares; 2023Q2: 570,417 shares; 2023Q3: 520,417 shares; 2023Q4: 750,000 shares; 2024Q1: 2,000,000 shares 2,000,000$18.9M0.93%+1,250,000Timeline
KALVKALVISTA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,650,000 shares; 2023Q2: 1,650,000 shares; 2023Q3: 1,650,000 shares; 2023Q4: 1,650,000 shares; 2024Q1: 1,590,000 shares 1,590,000$18.9M0.93%-60,000Timeline
ALLOALLOGENE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: 3,850,000 shares 3,850,000$17.2M0.85%newTimeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: 400,000 shares; 2024Q1: 400,000 shares 400,000$17.1M0.85%0Timeline
PRTAPROTHENA CORP PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 300,000 shares; 2023Q2: 300,000 shares; 2023Q3: 625,000 shares; 2023Q4: 665,000 shares; 2024Q1: 690,000 shares 690,000$17.1M0.84%+25,000Timeline
SANASANA BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: 1,545,000 shares 1,545,000$15.4M0.76%newTimeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 2,169,132 shares; 2023Q2: 1,819,132 shares; 2023Q3: 1,819,132 shares; 2023Q4: 1,819,132 shares; 2024Q1: 1,819,132 shares 1,819,132$15.1M0.75%0Timeline
POSEIDA THERAPEUTICS INCPOSEIDA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: 4,475,000 shares 4,475,000$14.3M0.71%new
ENGNENGENE HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: 727,900 shares 727,900$12.3M0.61%newTimeline
PRLDPRELUDE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 699,047 shares; 2023Q2: 2,495,018 shares; 2023Q3: 2,495,018 shares; 2023Q4: 2,568,287 shares; 2024Q1: 2,568,287 shares 2,568,287$12.2M0.6%0Timeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 710,644 shares; 2023Q2: 710,644 shares; 2023Q3: 646,058 shares; 2023Q4: 646,058 shares; 2024Q1: 671,358 shares 671,358$11.8M0.58%+25,300Timeline
IOVAIOVANCE BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 3,705,133 shares; 2023Q2: 3,705,133 shares; 2023Q3: 3,705,133 shares; 2023Q4: 1,400,000 shares; 2024Q1: 750,000 shares 750,000$11.1M0.55%-650,000Timeline
JSPRJASPER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: 350,000 shares 350,000$10.3M0.51%newTimeline
BOLDBOUNDLESS BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: 711,329 shares 711,329$10.1M0.5%newTimeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: 250,000 shares; 2024Q1: 250,000 shares 250,000$9.48M0.47%0Timeline
IPSCCENTURY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: 1,750,000 shares 1,750,000$7.32M0.36%newTimeline
ZNTLZENTALIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: 450,000 shares; 2023Q3: 450,000 shares; 2023Q4: 450,000 shares; 2024Q1: 450,000 shares 450,000$7.09M0.35%0Timeline
AMLXAMYLYX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 2,084,000 shares; 2023Q2: 2,084,000 shares; 2023Q3: 2,084,000 shares; 2023Q4: not reported; 2024Q1: 1,500,000 shares 1,500,000$4.26M0.21%newTimeline
ABSIABSCI CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: 700,000 shares 700,000$3.98M0.2%newTimeline
ATARA BIOTHERAPEUTICS INC C…ATARA BIOTHERAPEUTICS INC COM NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: 4,150,000 shares 4,150,000$2.88M0.14%new
BDTXBLACK DIAMOND THERAPEUTICS IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 2,014,858 shares; 2023Q2: 2,014,858 shares; 2023Q3: 506,000 shares; 2023Q4: 506,000 shares; 2024Q1: 506,000 shares 506,000$2.57M0.13%0Timeline
DIREXION SHS ETF TRDIREXION SHS ETF TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: 350,000 shares 350,000$2.55M0.13%new
BCABBIOATLA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 686,347 shares; 2023Q2: 686,347 shares; 2023Q3: 686,347 shares; 2023Q4: 686,347 shares; 2024Q1: 686,347 shares 686,347$2.36M0.12%0Timeline
OBIOORCHESTRA BIOMED HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 250,000 shares; 2023Q2: 250,000 shares; 2023Q3: 238,193 shares; 2023Q4: 238,193 shares; 2024Q1: 238,193 shares 238,193$1.26M0.06%0Timeline
TARAPROTARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 209,227 shares; 2023Q2: 209,227 shares; 2023Q3: 209,227 shares; 2023Q4: 209,227 shares; 2024Q1: 209,227 shares 209,227$839K0.04%0Timeline
MISTMILESTONE PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 698,861 shares; 2023Q2: 698,861 shares; 2023Q3: 309,007 shares; 2023Q4: 309,007 shares; 2024Q1: 309,007 shares 309,007$553K0.03%0Timeline
DBV TECHNOLOGIES S ADBV TECHNOLOGIES S AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,450,000 shares; 2023Q2: 1,450,000 shares; 2023Q3: 985,100 shares; 2023Q4: 500,000 shares; 2024Q1: 500,000 shares 500,000$375K0.02%0
NUVATION BIO INCNUVATION BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 266,666 shares; 2023Q2: 266,666 shares; 2023Q3: 266,666 shares; 2023Q4: 266,666 shares; 2024Q1: 266,666 shares 266,666$80.7K<0.01%0
SRZNWSURROZEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 66,666 shares; 2023Q2: 66,666 shares; 2023Q3: 66,666 shares; 2023Q4: 66,666 shares; 2024Q1: 66,666 shares 66,666$2.17K<0.01%0Timeline

Sold out in Q1 2024

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
MIRATI THERAPEUTICS INCMIRATI THERAPEUTICS INC3,201,440$188Mshares
IMMUNOGEN INCIMMUNOGEN INC2,961,000$87.8Mshares
KARUNA THERAPEUTICS INCKARUNA THERAPEUTICS INC250,000$79.1Mshares
KODKODIAK SCIENCES INC600,000$1.82Mshares
RAIN ONCOLOGY INCRAIN ONCOLOGY INC1,152,212$1.38Mshares
ATRECA INCATRECA INC2,202,333$291Kshares

How Q1 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000895345-24-000182 base2024-05-15acceptance time not in the bulk data set